Literature DB >> 17234445

Rac signaling in tumorigenesis and as target for anticancer drug development.

Di Sun1, Duo Xu, Baolin Zhang.   

Abstract

Rac GTPases are crucial signaling regulators in eukaryotic cells, acting downstream of many cell surface receptors. They play essential roles in diverse cellular functions including cytoskeleton dynamics, cell motility, cell survival and apoptosis. Their activities are controlled by a tightly regulated GDP/GTP cycle coupled with an alternation between cytoplasm and membrane compartments. Aberrant Rac signaling is found in some human cancers as a result of changes in the GTPase itself or in its regulation loops. This review highlights recent findings regarding the molecular and functional aspects of Rac that mediate tumorigenic transformation and metastasis. It also describes the cellular mechanisms that potentially explain the complex role of Rac in tumorigenesis. Finally, it discusses approaches for modulating Rac function as a potential anticancer strategy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17234445     DOI: 10.1016/j.drup.2006.12.001

Source DB:  PubMed          Journal:  Drug Resist Updat        ISSN: 1368-7646            Impact factor:   18.500


  18 in total

Review 1.  Influence of arsenate and arsenite on signal transduction pathways: an update.

Authors:  Ingrid L Druwe; Richard R Vaillancourt
Journal:  Arch Toxicol       Date:  2010-05-26       Impact factor: 5.153

2.  Expression of Rac-1 related to tumor depth, lymph node metastasis and patient prognosis in esophageal squamous cell carcinoma.

Authors:  Qing Yang; Guang-Yu Luo; Yin Li; Hong-Bo Shan; Hui-Yun Wang; Guo-Liang Xu
Journal:  Med Oncol       Date:  2013-09-12       Impact factor: 3.064

3.  Mutational analysis of Rac2 in gliomas.

Authors:  Ahmed Idbaih; Sophie Paris; Blandine Boisselier; Yannick Marie; Marc Sanson; Joëlle Thillet; Khê Hoang-Xuan; Jean-Yves Delattre
Journal:  J Neurooncol       Date:  2008-01-24       Impact factor: 4.130

4.  Silencing of D4-GDI inhibits growth and invasive behavior in MDA-MB-231 cells by activation of Rac-dependent p38 and JNK signaling.

Authors:  Yaqin Zhang; Leslie A Rivera Rosado; Sun Young Moon; Baolin Zhang
Journal:  J Biol Chem       Date:  2009-03-06       Impact factor: 5.157

5.  Perturbation of cytoskeleton dynamics by the opposing effects of Rac1 and Rac1b.

Authors:  Anjaruwee S Nimnual; Laura J Taylor; Marian Nyako; Hao-Hsuan Jeng; Dafna Bar-Sagi
Journal:  Small GTPases       Date:  2010-09

6.  Characterization of EHop-016, novel small molecule inhibitor of Rac GTPase.

Authors:  Brenda L Montalvo-Ortiz; Linette Castillo-Pichardo; Eliud Hernández; Tessa Humphries-Bickley; Alina De la Mota-Peynado; Luis A Cubano; Cornelis P Vlaar; Suranganie Dharmawardhane
Journal:  J Biol Chem       Date:  2012-03-01       Impact factor: 5.157

7.  Therapeutic ultrasound bypasses canonical syndecan-4 signaling to activate rac1.

Authors:  Claire M Mahoney; Mark R Morgan; Andrew Harrison; Martin J Humphries; Mark D Bass
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

8.  TIPE2 controls innate immunity to RNA by targeting the phosphatidylinositol 3-kinase-Rac pathway.

Authors:  Honghong Sun; Guohong Zhuang; Lihui Chai; Zhaojun Wang; Derek Johnson; Yuanfang Ma; Youhai H Chen
Journal:  J Immunol       Date:  2012-08-17       Impact factor: 5.422

9.  Role of Abl kinase and the Wave2 signaling complex in HIV-1 entry at a post-hemifusion step.

Authors:  Brooke Harmon; Nancy Campbell; Lee Ratner
Journal:  PLoS Pathog       Date:  2010-06-17       Impact factor: 6.823

10.  Lead exposure, polymorphisms in genes related to oxidative stress, and risk of adult brain tumors.

Authors:  Parveen Bhatti; Patricia A Stewart; Amy Hutchinson; Nathaniel Rothman; Martha S Linet; Peter D Inskip; Preetha Rajaraman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.